RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Timothy Turner to Humans

This is a "connection" page, showing publications Timothy Turner has written about Humans.
Connection Strength

0.124
  1. Turner T. Development of the polio vaccine: a historical perspective of Tuskegee University's role in mass production and distribution of HeLa cells. J Health Care Poor Underserved. 2012 Nov; 23(4 Suppl):5-10.
    View in: PubMed
    Score: 0.020
  2. Yates-Binder CC, Rodgers M, Jaynes J, Wells A, Bodnar RJ, Turner T. An IP-10 (CXCL10)-derived peptide inhibits angiogenesis. PLoS One. 2012; 7(7):e40812.
    View in: PubMed
    Score: 0.020
  3. Yates C, Sharp S, Jones J, Topps D, Coleman M, Aneja R, Jaynes J, Turner T. LHRH-conjugated lytic peptides directly target prostate cancer cells. Biochem Pharmacol. 2011 Jan 01; 81(1):104-10.
    View in: PubMed
    Score: 0.018
  4. Polzin A, Shipitsin M, Goi T, Feig LA, Turner TJ. Ral-GTPase influences the regulation of the readily releasable pool of synaptic vesicles. Mol Cell Biol. 2002 Mar; 22(6):1714-22.
    View in: PubMed
    Score: 0.010
  5. Enose-Akahata Y, Ngouth N, Ohayon J, Mandel M, Chavin J, Turner TJ, Jacobson S. Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1-Associated Neurologic Disease. Neurol Neuroimmunol Neuroinflamm. 2021 05; 8(3).
    View in: PubMed
    Score: 0.009
  6. Theodore SC, Davis M, Zhao F, Wang H, Chen D, Rhim J, Dean-Colomb W, Turner T, Ji W, Zeng G, Grizzle W, Yates C. MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1. Oncotarget. 2014 Jun 15; 5(11):3512-25.
    View in: PubMed
    Score: 0.006
  7. Wells KJ, Lima DS, Meade CD, Mu?oz-Antonia T, Scarinci I, McGuire A, Gwede CK, Pledger WJ, Partridge E, Lipscomb J, Matthews R, Matta J, Flores I, Weiner R, Turner T, Miele L, Wiese TE, Fouad M, Moreno CS, Lacey M, Christie DW, Price-Haywood EG, Quinn GP, Coppola D, Sodeke SO, Green BL, Lichtveld MY. Assessing needs and assets for building a regional network infrastructure to reduce cancer related health disparities. Eval Program Plann. 2014 Jun; 44:14-25.
    View in: PubMed
    Score: 0.006
  8. Jones J, Wang H, Zhou J, Hardy S, Turner T, Austin D, He Q, Wells A, Grizzle WE, Yates C. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells. Am J Pathol. 2012 Nov; 181(5):1836-46.
    View in: PubMed
    Score: 0.005
  9. Wang H, Jones J, Turner T, He QP, Hardy S, Grizzle WE, Welch DR, Yates C. Clinical and biological significance of KISS1 expression in prostate cancer. Am J Pathol. 2012 Mar; 180(3):1170-1178.
    View in: PubMed
    Score: 0.005
  10. Samuel T, Fadlalla K, Mosley L, Katkoori V, Turner T, Manne U. Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells. Anticancer Res. 2012 Jan; 32(1):61-71.
    View in: PubMed
    Score: 0.005
  11. Fadlalla K, Watson A, Yehualaeshet T, Turner T, Samuel T. Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival. Anticancer Res. 2011 Jan; 31(1):233-41.
    View in: PubMed
    Score: 0.004
  12. Theodore S, Sharp S, Zhou J, Turner T, Li H, Miki J, Ji Y, Patel V, Yates C, Rhim JS. Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient. Int J Oncol. 2010 Dec; 37(6):1477-82.
    View in: PubMed
    Score: 0.004
  13. Sodeke S, Turner T, Tarver W. The ethics of good communication in a complex research partnership. J Health Care Poor Underserved. 2010 Aug; 21(3 Suppl):35-45.
    View in: PubMed
    Score: 0.004
  14. Theodore SC, Rhim JS, Turner T, Yates C. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn Dis. 2010; 20(1 Suppl 1):S1-96-100.
    View in: PubMed
    Score: 0.004
  15. Samuel T, Fadlalla K, Turner T, Yehualaeshet TE. The flavonoid quercetin transiently inhibits the activity of taxol and nocodazole through interference with the cell cycle. Nutr Cancer. 2010; 62(8):1025-35.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support